View Cancer Clinical Trials

Details

Title Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry

IRB MONT1316

CC 16-688

Hospital Main Campus

Disease Brain

Description

To further understand performance and utilization of NBS in current standard of care, post-market multi-center registry called LAANTERN (Laser Ablation of Abnormal Neurological Tissue using Robotic Neuroblate system) is designed to collect baseline, procedural and follow-up data on patients that are already scheduled to be treated with NBS in observational manner for publication purposes.

Inclusion Criteria

1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
2. Patient who is to undergo thermal therapy by the NeuroBlate®. System for treatment of their neurological disorder

Exclusion Criteria

1. Patient who is, or is expected to be inaccessible for follow-up
2. Patient meets any exclusion criteria required by local law (e.g. age)
3. Other concurrent medical or other condition (chronic or acute in nature) that in the opinion of the investigator may prevent participation or otherwise render patient ineligibility for the study